Claros Diagnostics plans to launch its point-of-care system for prostate-specific antigen (PSA) testing in Europe, after CE marking the device. PSA is already commonly used to screen for prostate cancer, but Claros claims that its product is the first POC PSA test to analyse ...
Please Login to read the full article.
